![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | C07K 7/08 | |
C07K 14/00 | |||
G01N 33/68 | |||
A61K 39/395 | |||
C07K 14/005 |
(11) | Patento numeris | 2859011 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 13727202.7 |
Europos patento paraiškos padavimo data | 2013-06-06 | |
(97) | Europos patento paraiškos paskelbimo data | 2015-04-15 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2019-12-11 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/EP2013/061751 |
Data | 2013-06-06 |
(87) | Numeris | WO 2013/182661 |
Data | 2013-12-12 |
(30) | Numeris | Data | Šalis |
201261656256 P | 2012-06-06 | US |
(72) |
S RENSEN, Birger, NO
ÖKVIST, Mats, NO
HOVDEN, Arnt Ove, NO
GR NVOLD, Maja Sommerfelt, NO
|
(73) |
Bionor Immuno AS,
Klostergata 33 P.O. Box 2870, 3702 Skien,
NO
|
(54) | PEPTIDES DERIVED FROM VIRAL PROTEINS FOR USE AS IMMUNOGENS AND DOSAGE REACTANTS |
PEPTIDES DERIVED FROM VIRAL PROTEINS FOR USE AS IMMUNOGENS AND DOSAGE REACTANTS |